Clinical Trial Update: Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and drug blood levels of micafungin (Mycamine) in infants and toddlers with invasive candidiasis, esophageal candidiasis, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Invasive Candidiasis, Esophageal Candidiasis | Phase 1 | Status: COMPLETED